- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 353.8M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 357.08M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 356.78M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 354.84M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 351.89M sh |
| Capex | Q3 2025 · Sep 27, 2025 | $25.64M |
| Capex | Q3 2025 · Sep 28, 2024 | $32.18M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2025 | −$44.27M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2024 | $196.81M |
| Long Term Debt | Q3 2025 · Sep 27, 2025 | $2.21B |
| Long Term Debt | Q3 2025 · Dec 28, 2024 | $2.19B |
| Long Term Debt | Q3 2025 · Sep 28, 2024 | $3.21B |
| Cash And Equivalents | Q3 2025 · Sep 27, 2025 | $217.57M |
| Cash And Equivalents | Q3 2025 · Dec 28, 2024 | $214.85M |
| Cash And Equivalents restated | Q3 2025 · Sep 28, 2024 | $316.8M |
| Stockholders Equity | Q3 2025 · Sep 27, 2025 | $446.44M |
| Stockholders Equity | Q3 2025 · Jun 28, 2025 | $166.36M |
| Stockholders Equity | Q3 2025 · Dec 28, 2024 | $34.01M |
| Stockholders Equity | Q3 2025 · Sep 28, 2024 | $149.34M |
| Stockholders Equity | Q3 2025 · Jun 29, 2024 | $64.4M |
| Stockholders Equity | Q3 2025 · Dec 30, 2023 | $419.35M |
| Current Liabilities | Q3 2025 · Sep 27, 2025 | $1.24B |
| Current Liabilities | Q3 2025 · Dec 28, 2024 | $1.25B |
| Current Liabilities | Q3 2025 · Sep 28, 2024 | $1.58B |
| Total Liabilities | Q3 2025 · Sep 27, 2025 | $3.83B |
| Total Liabilities | Q3 2025 · Dec 28, 2024 | $3.81B |
| Total Liabilities | Q3 2025 · Sep 28, 2024 | $5.31B |
| Current Assets | Q3 2025 · Sep 27, 2025 | $1.88B |
| Current Assets | Q3 2025 · Dec 28, 2024 | $1.72B |
| Current Assets | Q3 2025 · Sep 28, 2024 | $2.34B |
| Total Assets | Q3 2025 · Sep 27, 2025 | $4.28B |
| Total Assets | Q3 2025 · Dec 28, 2024 | $3.84B |
| Total Assets | Q3 2025 · Sep 28, 2024 | $5.46B |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $0.76 |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $0.96 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $0.08 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | −$0.87 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $0.76 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $0.97 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $0.09 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | −$0.87 |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $255.92M |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $749.98M |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $279.44M |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $903.01M |
| Net Income | Q3 2025 · Sep 27, 2025 | $270.74M |
| Net Income | Q3 2025 · Sep 27, 2025 | $342.89M |
| Net Income | Q3 2025 · Sep 28, 2024 | $29.95M |
| Net Income | Q3 2025 · Sep 28, 2024 | −$307.55M |
| Operating Income | Q3 2025 · Sep 27, 2025 | $107.53M |
| Operating Income | Q3 2025 · Sep 27, 2025 | $342.09M |
| Operating Income restated | Q3 2025 · Sep 28, 2024 | $94.04M |
| Operating Income restated | Q3 2025 · Sep 28, 2024 | $66.25M |
| Gross Profit | Q3 2025 · Sep 27, 2025 | $363.45M |
| Gross Profit | Q3 2025 · Sep 27, 2025 | $1.09B |
| Gross Profit restated | Q3 2025 · Sep 28, 2024 | $373.48M |
| Gross Profit restated | Q3 2025 · Sep 28, 2024 | $969.25M |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $528.23M |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $1.55B |
| Cost Of Revenue restated | Q3 2025 · Sep 28, 2024 | $526.89M |
| Cost Of Revenue restated | Q3 2025 · Sep 28, 2024 | $1.65B |
| Revenue | Q3 2025 · Sep 27, 2025 | $891.68M |
| Revenue | Q3 2025 · Sep 27, 2025 | $2.64B |
| Revenue restated | Q3 2025 · Sep 28, 2024 | $900.37M |
| Revenue restated | Q3 2025 · Sep 28, 2024 | $2.62B |